Hepatitis B virus and hepatitis C virus co-infection: A therapeutic challenge

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 1, 2013, Pages

  Hamzaoui, Lamine ^a   El Bouchtili, Souheil ^a   Siai, Karima ^a   Mahmoudi, Moufida ^a   Azzouz, Mohamed Msaddak ^a  

^a Hopital Mohamed Tahar Maamouri   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; PEGINTERFERON; RIBAVIRIN; VIRUS DNA;

ADJUVANT THERAPY; ADULT; ANTIVIRAL THERAPY; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CASE REPORT; CLINICAL DECISION MAKING; DIABETES MELLITUS; DRUG TOLERABILITY; FIBROTEST; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LIVER FUNCTION TEST; MALE; MIXED INFECTION; OBESITY; PHYSICAL EXAMINATION; RELAPSE; RISK FACTOR; SEROLOGY; SMOKING; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIROLOGY; VIRUS LOAD; VIRUS STRAIN;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; GUANINE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RECURRENCE; RIBAVIRIN;

EID: 84873155197     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.08.001     Document Type: Article

References (49)

1. Benvegnu L., Fattovich G., Noventa F., Tremolada F., Chemello L., Cecchetto A., et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994, 74:2442-2448.
2. Chiaramonte M., Stroffolini T., Vian A., Stazi M.A., Floreani A., Lorenzoni U., et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999, 85:2132-2137.
3. Weltman M.D., Brotodihardjo A., Crewe E.B., Farrell G.C., Bilous M., Grierson J.M., et al. Co-infection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 1995, 2:39-45.
4. Kaklamani E., Trichopoulos D., Tzonou A., Zavitsanos X., Koumantaki Y., Hatzakis A., et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991, 265:1974-1976.
5. Crockett S.D., Keeffe E.B. Natural history and treatment of hepatitis B virus and hepatitis C virus co-infection. Ann Clin Microbiol Antimicrob 2005, 4:13.
6. Zhang Y.Y., Hansson B.G., Kuo L.S., Widell A., Nordenfelt E. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 1993, 17:538-544.
7. Cacciola I., Pollicino T., Squadrito G., Cerenzia G., Orlando M.E., Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999, 341:22-26.
8. Squadrito G., Orlando M.E., Pollicino T., Raffa G., Restuccia T., Cacciola I., et al. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am J Gastroenterol 2002, 97:1518-1523.
9. Crespo J., Lozano J.L., de la Cruz F., Rodrigo L., Rodríguez M., San Miguel G., et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994, 89:1147-1151.
10. Fattovich G., Tagger A., Brollo L., Giustina G., Pontisso P., Realdi G., et al. Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis 1991, 163:400-402.
11. Gaeta G.B., Stornaiuolo G., Precone D.F., Lobello S., Chiaramonte M., Stroffolini T., et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 2003, 39:1036-1041.
12. Dai C.Y., Yu M.L., Chuang W.L., Lin Z.Y., Chen S.C., Hsieh M.Y., et al. Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 2001, 16:636-640.
13. Nguyen L.H., Ko S., Wong S.S., Tran P.S., Trinh H.N., Garcia R.T., et al. Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection. Hepatology 2011, 53(6):1839-1845.
14. Pallas J.R., Farinas-Alvarez C., Prieto D., Delgado-Rodriguez M. Co-infections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. Eur J Epidemiol 1999, 15:699-704.
15. Reddy G.A., Dakshinamurthy K.V., Neelaprasad P., Gangadhar T., Lakshmi V. Prevalence of HBV and HCV dual infection in patients on haemodialysis. Indian J Med Microbiol 2005, 23:41-43.
16. Aroldi A., Lampertico P., Montagnino G., Passerini P., Villa M., Campise M.R., et al. Natural history of hepatitis B and C in renal allograft recipients. Transplantation 2005, 79:1132-1136.
17. Kalinowska-Nowak A., Bociaga-Jasik M., Garlicki A., Skwara P. Prevalence of hepatotropic viruses HBV and HCV in HIV-infected patients from Southern region of Poland. Acta Virologica 2000, 44:23-28.
18. Zhou J., Dore G.J., Zhang F., Lim P.L., Chen Y.M., TREAT Asia HIV Observational Database Hepatitis B and C virus co-infection in the TREAT Asia HIV observational database. J Gastroenterol Hepatol 2007, 22:1510-1518.
19. Irshad M., Peter S. Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian J Gastroenterol 2002, 21:183-184.
20. Brotman B., Prince A.M., Huima T., Richardson L., van den Ende M.C., Pfeifer U. Interference between non-A, non-B and hepatitis B virus infection in chimpanzees. J Med Virol 1983, 11:191-205.
21. Bradley D.W., Maynard J.E., Mc Caustland K.A., Murphy B.L., Cook E.H., Ebert J.W. Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections. J Med Virol 1983, 11:207-213.
22. Fong T.L., Di Bisceglie A.M., Waggoner J.G., Banks S.M., Hoofnagle J.H. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991, 14:64-67.
23. Chu C.M., Yeh C.T., Liaw Y.F. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 1998, 36:2084-2086.
24. Liaw Y.F., Tsai S.L., Chang J.J., Sheen I.S., Chien R.N., Lin D.Y., et al. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994, 106:1048-1053.
25. Liaw Y.F., Lin S.M., Sheen I.S., Chu C.M. Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg elimination. Infection 1991, 19:250-251.
26. Sheen I.S., Liaw Y.F., Lin D.Y., Chu C.M. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 1994, 170:358-361.
27. Shih C.M., Lo S.J., Miyamura T., Chen S.Y., Lee Y.H. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in Hu-H7 cells. J Virol 1993, 67:5823-5832.
28. Shih C.M., Chen C.M., Chen S.Y., Lee Y.H. Modulation of the transsuppression activity of hepatitis C virus core protein by phosphorylation. J Virol 1995, 69:1160-1171.
29. Schuttler C.G., Fiedler N., Schmidt K., Repp R., Gerlich W.H., Schaefer S. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 2002, 37:855-862.
30. Chen S.Y., Kao C.F., Chen C.M., Shih C.M., Hsu M.J., Chao C.H., et al. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 2003, 278:591-607.
31. Zarski J.P., Bohn B., Bastie A., Pawlotsky J.M., Baud M., Bost-Bezeaux F., et al. Characteristic of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998, 28:27-33.
32. Sato S., Fujiyama S., Tanaka M., Yamasaki K., Kuramoto I., Kawano S., et al. Co-infection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994, 21:159-166.
33. Ohkawa K., Hayashi N., Yuki N., Hagiwara H., Kato M., Yamamoto K., et al. virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol 1994, 21:509-514.
34. Ohkawa K., Hayashi N., Yuki N., Masuzawa M., Kato M., Yamamoto K., et al. Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients co-infected with both viruses. J Med Virol 1995, 46:258-264.
35. Pontisso P., Gerotto M., Ruvoletto M.G., Fattovich G., Chemello L., Tisminetzky S., et al. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J Med Virol 1996, 48:157-160.
36. Chu C.J., Lee S.D. Hepatitis B virus/hepatitis C virus co-infection: epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 2008, 23(4):512-520.
37. Chuang W.L., Dai C.Y., Chang W.Y., Lee L.P., Lin Z.Y., Chen S.C., et al. Viral interaction and responses in chronic hepatitis C and B co-infected patients with interferon-alpha plus ribavirin combination therapy. Antivir Ther 2005, 10:125-133.
38. Renou C., Cadranel J.F., Pariente A., Pénaranda G., Bourlière M., Halfon P., et al. Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers. Eur J Gastroenterol Hepatol 2008, 20(12):1235-1237.
39. Sagnelli E., Coppola N., Scolastico C., Filippini P., Santantonio T., Stroffolini T., et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000, 32:1106-1110.
40. Kew M.C., Yu M.C., Kedda M.A., Coppin A., Sarkin A., Hodkinson J. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology 1997, 112:184-187.
41. Kirk G.D., Lesi O.A., Mendy M., Akano A.O., Sam O., Goedert J.J., et al. The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 2004, 39:211-219.
42. Chu C.J., Lee S.D., Hepatitis B virus/hepatitis C virus co-infection: epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 2008, 23:512-520.
43. Burt M., Chapman B.A., Scrimshaw B.J., Jennings L.C., George P.M. Concurrent hepatitis B and C infection treated successfully with alpha-interferon. Aust N Z J Med 1993, 23:411-412.
44. Gehenot M., Marcellin P., Colin J.F., Martinot M., Benhamou J.P., Erlinger S. Alpha-interferon therapy in HBsAg positive patients with chronic hepatitis C. Hepatology 1995, 22:116A.
45. Guptan R.C., Thakur V., Raina V., Sarin S.K. Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J Gastroenterol Hepatol 1999, 14:893-898.
46. Utili R., Zampino R., Bellopede P., Marracino M., Ragone E., Adinolfi L.E., et al. Dual or single hepatitis B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment. Blood 1999, 94:4046-4052.
47. Villa E., Grottola A., Buttafoco P., Colantoni A., Bagni A., Ferretti I., et al. High doses of alpha-interferon are required in chronic hepatitis due to co-infection with hepatitis B virus and hepatitis C virus: long-term results of a prospective randomized trial. Am J Gastroenterol 2001, 96:2973-2977.
48. Craxì A., Pawlotsky J.M., Wedemeyer H., Bjoro K., Flisiak R., Forns X., et al. EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol 2011, 55(2):245-264.
49. Liu C.J., Chuang W.L., Lee C.M., Wu S.S., Liao L.Y., Kuo H.T., et al. An open label, comparative, multicenter study of peginterferon alfa-2a plus ribavirin in the treatment of patients with chronic hepatitis C/hepatitis B co-infection versus those with chronic hepatitis C mono-infection. Hepatology 2007, 46(Suppl. 1):341A.